|
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection
|
journal
|
January 2016 |
|
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
|
journal
|
January 2019 |
|
Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics
|
journal
|
August 2018 |
|
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection
|
journal
|
February 2023 |
|
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
|
journal
|
August 2020 |
|
Fecal microbiota transplantation for rheumatoid arthritis: A case report
|
journal
|
December 2020 |
|
Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)
|
journal
|
November 2019 |
|
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial
|
journal
|
October 2017 |
|
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial
|
journal
|
June 2019 |
|
Mechanisms and consequences of intestinal dysbiosis
|
journal
|
March 2017 |
|
Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration
|
journal
|
February 2020 |
|
Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial
|
journal
|
December 2022 |
|
Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis
|
journal
|
May 2018 |
|
The gut microbiome in neurological disorders
|
journal
|
February 2020 |
|
Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease
|
journal
|
March 2017 |
|
Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
|
journal
|
October 2018 |
|
The role of short-chain fatty acids in Clostridioides difficile infection: A review
|
journal
|
June 2022 |
|
Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway
|
journal
|
January 2021 |
|
The live biotherapeutic Blautia stercoris MRx0006 attenuates social deficits, repetitive behaviour, and anxiety-like behaviour in a mouse model relevant to autism
|
journal
|
November 2022 |
|
The links between gut microbiota and obesity and obesity related diseases
|
journal
|
March 2022 |
|
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
|
journal
|
January 2015 |
|
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
|
journal
|
April 2020 |
|
Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma
|
journal
|
June 2015 |
|
Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids
|
journal
|
April 2018 |
|
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors
|
journal
|
October 2021 |
|
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
|
journal
|
April 2022 |
|
Dysfunctional Families: Clostridium scindens and Secondary Bile Acids Inhibit the Growth of Clostridium difficile
|
journal
|
January 2015 |
|
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
|
journal
|
May 2017 |
|
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
|
journal
|
October 2017 |
|
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
|
journal
|
November 2020 |
|
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|
journal
|
December 2021 |
|
Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation
|
journal
|
March 2016 |
|
Selección del donante para la transferencia de microbiota fecal. Documento de posicionamiento de la Societat Catalana de Digestologia y de la Societat Catalana de Malalties Infeccioses i Microbiologia Clínica
|
journal
|
February 2021 |
|
Mo1667 FECAL MICROBIOTA TRANSPLANTATION FOR CHILDREN WITH AUTISM SPECTRUM DISORDER
|
journal
|
June 2019 |
|
Fecal Microbiota Transplantation
|
journal
|
March 2017 |
|
Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production
|
journal
|
April 2016 |
|
Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial
|
journal
|
June 2022 |
|
Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations
|
journal
|
October 2023 |
|
Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis
|
journal
|
June 2019 |
|
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
|
journal
|
June 2016 |
|
Discovery and delivery strategies for engineered live biotherapeutic products
|
journal
|
March 2022 |
|
Clostridioides difficile
|
journal
|
December 2018 |
|
Multi-omic analyses identify mucosa bacteria and fecal metabolites associated with weight loss after fecal microbiota transplantation
|
journal
|
September 2022 |
|
Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study
|
journal
|
June 2017 |
|
Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii
|
journal
|
August 2011 |
|
An obesity-associated gut microbiome with increased capacity for energy harvest
|
journal
|
December 2006 |
|
The Human Microbiome Project
|
journal
|
October 2007 |
|
A human gut microbial gene catalogue established by metagenomic sequencing
|
journal
|
March 2010 |
|
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
|
journal
|
February 2012 |
|
Human gut microbiome viewed across age and geography
|
journal
|
May 2012 |
|
A metagenome-wide association study of gut microbiota in type 2 diabetes
|
journal
|
September 2012 |
|
Diversity, stability and resilience of the human gut microbiota
|
journal
|
September 2012 |
|
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
|
journal
|
July 2013 |
|
Medicines from microbiota
|
journal
|
April 2013 |
|
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
|
journal
|
October 2018 |
|
Dysbiosis and the immune system
|
journal
|
March 2017 |
|
Microbiota in health and diseases
|
journal
|
April 2022 |
|
Effect of fecal microbiota transplantation route of administration on gut colonization and host response in preterm pigs
|
journal
|
October 2018 |
|
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient
|
journal
|
July 2022 |
|
Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes
|
journal
|
September 2021 |
|
Towards a deeper understanding of the vaginal microbiota
|
journal
|
March 2022 |
|
The gut microbiota influences anticancer immunosurveillance and general health
|
journal
|
April 2018 |
|
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
|
journal
|
May 2019 |
|
Gut microbiota in human metabolic health and disease
|
journal
|
September 2020 |
|
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
|
journal
|
October 2022 |
|
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|
journal
|
February 2019 |
|
The microbiome, cancer, and cancer therapy
|
journal
|
March 2019 |
|
Vaginal microbiome transplantation in women with intractable bacterial vaginosis
|
journal
|
October 2019 |
|
Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial
|
journal
|
July 2021 |
|
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
|
journal
|
February 2022 |
|
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
|
journal
|
September 2022 |
|
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
|
journal
|
May 2017 |
|
A taxonomic signature of obesity in a large study of American adults
|
journal
|
June 2018 |
|
Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases
|
journal
|
March 2000 |
|
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
|
journal
|
July 2015 |
|
Pathobiology of Helicobacter pylori–Induced Gastric Cancer
|
journal
|
January 2016 |
|
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes
|
journal
|
August 2018 |
|
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
|
journal
|
May 2020 |
|
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
|
journal
|
February 2023 |
|
Burden of Clostridium difficile Infection in the United States
|
journal
|
February 2015 |
|
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
|
journal
|
November 2019 |
|
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
|
journal
|
January 2007 |
|
Vaginal microbiome of reproductive-age women
|
journal
|
June 2010 |
|
Lactiplantibacillus plantarum as a promising adjuvant for neurological disorders therapy through the brain-gut axis and related action pathways
|
journal
|
November 2023 |
|
Current research progress, opportunities, and challenges of Limosillactobacillus reuteri -based probiotic dietary strategies
|
journal
|
June 2024 |
|
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases
|
journal
|
March 2023 |
|
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders
|
journal
|
October 2019 |
|
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection
|
journal
|
February 2023 |
|
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
|
journal
|
March 2016 |
|
Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review
|
journal
|
January 2017 |
|
Microbiota Insights in Clostridium Difficile Infection and Inflammatory Bowel Disease
|
journal
|
March 2020 |
|
Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
|
journal
|
January 2022 |
|
Species- and strain-level assessment using rrn long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects
|
journal
|
May 2022 |
|
Emerging issues in probiotic safety: 2023 perspectives
|
journal
|
March 2023 |
|
Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
|
journal
|
March 2019 |
|
Combined Oral Fecal Capsules Plus Fecal Enema as Treatment of Late-Onset Autism Spectrum Disorder in Children: Report of a Small Case Series
|
journal
|
October 2016 |
|
Development of synthetic biotics as treatment for human diseases
|
journal
|
January 2022 |
|
Facing a new challenge
|
journal
|
May 2019 |
|
Fecal microbiota transplantation to treat Parkinson's disease with constipation
|
journal
|
June 2019 |
|
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
|
journal
|
October 2011 |
|
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
|
journal
|
March 2020 |
|
Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?
|
journal
|
January 2020 |
|
Quality of probiotic products for preterm infants: Contamination and missing strains
|
journal
|
September 2019 |
|
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles
|
journal
|
April 2016 |
|
Review article: the future of microbiome‐based therapeutics
|
journal
|
May 2022 |
|
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
|
journal
|
August 2017 |
|
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
|
journal
|
December 2010 |
|
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
|
journal
|
September 2013 |
|
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
|
journal
|
August 2000 |
|
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
|
journal
|
November 2017 |
|
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
|
journal
|
March 2018 |
|
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
|
journal
|
February 2021 |
|
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
|
journal
|
February 2021 |
|
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
|
journal
|
August 2023 |
|
Temporal Dynamics of the Human Vaginal Microbiota
|
journal
|
May 2012 |
|
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
|
journal
|
December 2018 |
|
Antibiotic Usage and Risk of Colonization and Infection with Antibiotic-Resistant Bacteria: a Hospital Population-Based Study
|
journal
|
October 2009 |
|
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
|
journal
|
December 2017 |
|
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
|
journal
|
June 2013 |
|
Bacteriophage transfer during faecal microbiota transplantation inClostridium difficileinfection is associated with treatment outcome
|
journal
|
May 2017 |
|
The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
|
journal
|
August 2018 |
|
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model
|
journal
|
August 2019 |
|
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
|
journal
|
December 2019 |
|
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model
|
journal
|
March 2020 |
|
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
|
journal
|
October 2020 |
|
Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial
|
journal
|
March 2021 |
|
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
|
journal
|
January 2022 |
|
Revisiting the donor screening protocol of faecal microbiota transplantation (FMT): a systematic review
|
journal
|
May 2023 |
|
The Microbiota-Gut-Brain Axis
|
journal
|
October 2019 |
|
The Effect of Fecal Microbiota Transplantation on a Child with Tourette Syndrome
|
journal
|
January 2017 |
|
Colonization of the Human Gut by E. coli and Colorectal Cancer Risk
|
journal
|
February 2014 |
|
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
|
journal
|
February 2021 |
|
The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
|
journal
|
January 2022 |
|
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial
|
journal
|
April 2022 |
|
Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
|
journal
|
August 2018 |
|
The association between fecal enterotoxigenic B. fragilis with colorectal cancer
|
journal
|
September 2019 |
|
Radiotherapy and the gut microbiome: facts and fiction
|
journal
|
January 2021 |
|
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
|
journal
|
March 2022 |
|
Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
|
journal
|
November 2022 |
|
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study
|
journal
|
January 2017 |
|
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
|
journal
|
February 2020 |
|
Synthetic bacterial consortia transplantation for the treatment of Gardnerella vaginalis-induced bacterial vaginosis in mice
|
journal
|
March 2023 |
|
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS
|
journal
|
July 2018 |
|
Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case Report
|
journal
|
August 2018 |
|
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial
|
journal
|
January 2019 |
|
A Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability of (Thetanix) Bacteroides thetaiotaomicron in Adolescent Crohn's Disease
|
journal
|
January 2021 |
|
Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer
|
journal
|
September 2016 |
|
Clinical and immune effects of fecal microbiota transplantation in children with acute graft-versus-host disease
|
journal
|
April 2021 |
|
Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens
|
journal
|
July 2017 |
|
Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
|
journal
|
May 2023 |
|
A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease
|
journal
|
April 2019 |
|
Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies
|
journal
|
June 2020 |
|
Microbiome engineering: engineered live biotherapeutic products for treating human disease
|
journal
|
September 2022 |
|
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
|
journal
|
October 2021 |
|
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
|
journal
|
July 2022 |
|
Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
|
journal
|
March 2022 |
|
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
|
journal
|
March 2019 |
|
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
|
journal
|
June 2021 |
|
Live Biotherapeutic Products, A Road Map for Safety Assessment
|
journal
|
June 2020 |
|
Fresh Versus Frozen Stool for Fecal Microbiota Transplantation—Assessment by Multimethod Approach Combining Culturing, Flow Cytometry, and Next-Generation Sequencing
|
journal
|
July 2022 |
|
In vitro Characterization of Gut Microbiota-Derived Bacterial Strains With Neuroprotective Properties
|
journal
|
September 2019 |
|
Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis
|
journal
|
September 2020 |
|
Microbiota-Derived Metabolites in Tumor Progression and Metastasis
|
journal
|
August 2020 |
|
Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease
|
journal
|
March 2022 |
|
Amelioration of Maternal Immune Activation-Induced Autism Relevant Behaviors by Gut Commensal Parabacteroides goldsteinii
|
journal
|
October 2022 |
|
Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis
|
journal
|
March 2021 |
|
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
|
journal
|
July 2022 |
|
Probiotic Supplementation in a Clostridium difficile-Infected Gastrointestinal Model Is Associated with Restoring Metabolic Function of Microbiota
|
journal
|
December 2019 |
|
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
|
journal
|
September 2021 |
|
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
|
journal
|
July 2018 |
|
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update
|
journal
|
January 2016 |
|
Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report
|
journal
|
January 2017 |
|
Dysbiosis and liver diseases (Review)
|
journal
|
July 2021 |
|
Therapeutic Potential of Escherichia coli Nissle 1917 in Clinically Remission-attained Ulcerative Colitis Patients: A Hospital-based Cohort Study
|
journal
|
January 2021 |
|
Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation
|
journal
|
July 2019 |
|
Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
|
journal
|
January 2022 |